Richard K. Prins - Nov 12, 2024 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Stock symbol
AMPH
Transactions as of
Nov 12, 2024
Transactions value $
-$202,261
Form type
4
Date filed
11/13/2024, 06:55 PM
Previous filing
Aug 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $41.7K +2.5K +7.36% $16.69 36.5K Nov 12, 2024 Direct
transaction AMPH Common Stock Sale -$244K -5K -13.71% $48.80 31.5K Nov 12, 2024 Direct F1
transaction AMPH Common Stock Gift $0 -1K -3.18% $0.00 30.5K Nov 12, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Stock Option (right to buy) Options Exercise $0 -2.5K -37.43% $0.00 4.18K Nov 12, 2024 Common Stock 2.5K $16.69 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.797 to $48.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F2 Shares subject to the option are fully vested and immediately exercisable.